Shanghai, China

Peipei Xia

This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Yipurun (Shanghai) Biotechnology Co., Ltd.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peipei Xia. Retrieved from https://idiyas.com/inventor/peipei-xia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Peipei Xia - Revolutionizing Technology in Shanghai

Introduction: Peipei Xia is a pioneering inventor based in Shanghai, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Peipei Xia holds several patents in the areas of artificial intelligence, robotics, and sustainable energy solutions, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Peipei Xia has worked with leading tech companies in Shanghai, driving innovation and spearheading projects that have had a significant impact on the industry.

Collaborations: Throughout her career, Peipei Xia has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of creativity and excellence in all her projects.

Conclusion: Peipei Xia's relentless pursuit of innovation and her passion for pushing the boundaries of technology make her a true trailblazer in the field, inspiring the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…